Skip to main content
. Author manuscript; available in PMC: 2021 Aug 16.
Published in final edited form as: Int J Gynecol Cancer. 2020 Jul 20;30(8):1162–1168. doi: 10.1136/ijgc-2020-001573

Table 2:

Complications and Readmissions

Variable Total Cohort Open Planned MIS p
Totals 147 37 110

30-Day Complication <0.001
 No 121 (82%) 20 (54%) 101 (92%)
 Yes 26 (18%) 17 (46%) 9 (8%)

Complication Grade 0.24
 1 11 (42%) 6 (35%) 5 (56%)
 2 11 (42%) 9 (53%) 2 (22%)
 3 3 (12%) 2 (12%) 1 (11%)
 4 0 (0%) 0 (0%) 0 (0%)
 5 1 (4%) 0 (0%) 1 (11%)

Grade ≥3 Complication 0.18
 No 22 (85%) 15 (88%) 7 (78%)
 Yes 4 (15%) 2 (12%) 2 (22%)

Readmission <30 days 0.06
 No 142 (97%) 34 (92%) 108 (98%)
 Yes 5 (3%) 3 (8%) 2 (2%)

MIS, minimally invasive surgery